Search Results

Your search for Mark Lazenby, PhD, APRN, FAPOS,Mark Lazenby, PhD, APRN, FAPOS matches 2 pages

Showing 1 - 2

By Mark Lazenby, PhD, APRN, FAPOS / 2015 IPOS APOS World Congress of Psycho-Oncology

Mark Lazenby, PhD, APRN, FAPOS, on Distress Screening in the Community Setting

Mark Lazenby, PhD, APRN, FAPOS, of the Yale School of Nursing, discusses the APOS–ACCC project to screen for psychosocial distress in community cancer centers. These model programs improve patient care and the patient experience.

By Jo Cavallo / May 1, 2014

American Psychosocial Oncology Society Launches Psychosocial Distress Program

In February, the American Psychosocial Oncology Society (APOS) held its 11th Annual Conference in Tampa, Florida, and it marked a number of firsts. With over 500 registrants and more than 300 abstracts presented over the 3-day program, this was the largest APOS event to date. The theme of this...

Nov

Today In Oncology

Search Results

Your search for Mark Lazenby, PhD, APRN, FAPOS,Mark Lazenby, PhD, APRN, FAPOS matches 2 pages

Mark Lazenby, PhD, APRN, FAPOS, on Distress Screening in the Community Setting

American Psychosocial Oncology Society Launches Psychosocial Distress Program

Firefighters May Be Exposed to Chemicals Associated With Breast Cancer

FDA Grants Accelerated Approval to Zanidatamab-hrii for Previously Treated Unresectable or Metastatic HER2-Positive Biliary Tract Cancer

Novel EGFR Inhibitor Firmonertinib Shows Activity in Rare Subtype of NSCLC

Outcomes of Immune Checkpoint Inhibitor Treatment for Cancer in Black vs White Patients in the U.S. VHA System

Pooled Analysis of Long-Term Outcomes With Nivolumab With or Without Ipilimumab in Advanced Melanoma